Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tscan Therapeutics Inc
(NQ:
TCRX
)
6.935
+0.015 (+0.22%)
Streaming Delayed Price
Updated: 9:53 AM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,345
Open
6.820
Bid (Size)
6.900 (3)
Ask (Size)
6.970 (3)
Prev. Close
6.920
Today's Range
6.820 - 7.060
52wk Range
1.620 - 9.000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TScan Therapeutics Announces Closing of Upsized Public Offering
Today 10:05 EDT
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
April 17, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
+21.45%
+21.45%
1 Month
-0.50%
-0.50%
3 Month
+31.84%
+31.84%
6 Month
+104.57%
+104.57%
1 Year
+206.86%
+206.86%
More News
Read More
TScan Therapeutics: Q4 Earnings Insights
March 06, 2024
Via
Benzinga
Recap: TScan Therapeutics Q3 Earnings
November 09, 2023
Via
Benzinga
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
April 16, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
April 16, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer
April 08, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
March 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
March 17, 2024
Via
InvestorPlace
TCRX Stock Earnings: TScan Therapeutics Beats EPS, Beats Revenue for Q4 2023
March 06, 2024
Via
InvestorPlace
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 06, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR
February 26, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR
February 14, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development
February 06, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
January 29, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR
January 18, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress
January 04, 2024
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
December 09, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations
December 07, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition
December 04, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
December 04, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years
November 30, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023
From
TScan Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.